"NeuroOne’s nerve ablation system secures FDA clearance" was originally created and published by Medical Device Network, a ...

NeuroOne Medical Technologies Corporation NMTC recently received FDA 510(k) clearance for its OneRF Trigeminal Nerve Ablation ...

Trigeminal nerve ablation, a minimally invasive procedure, uses RF energy to destroy abnormal tissue and relieve severe, ...

FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical ...

FDA clearance of the OneRF device for trigeminal neuralgia marks the company’s first expansion into the treatment of chronic pain. NeuroOne also sells its FDA-cleared OneRF sEEG brain ablation system ...

This clearance leverages the Company’s proprietary OneRF ® Ablation System RF generator platform for the treatment of trigeminal neuralgia, a chronic pain condition affecting approximately ...

This clearance utilizes the company's proprietary OneRF Ablation System RF generator platform for the treatment of trigeminal neuralgia, a chronic facial pain condition that affects approximately ...

NeuroOne Medical Technologies(NASDAQ:NMTC) reported fiscal third quarter 2025 earnings on August 14, 2025, with product revenue up 105% year-over-year to $1.7 million and product gross margins rising ...

NeuroOne Medical Technologies Corporation NMTC recently received FDA 510 (k) clearance for its OneRF Trigeminal Nerve Ablation System, a minimally invasive solution for treating severe facial pain.

This clearance leverages the Company’s proprietary OneRF ® Ablation System RF generator platform for the treatment of trigeminal neuralgia, a chronic pain condition affecting approximately ...